The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 23, 2024
Filed:
Feb. 10, 2023
Applicant:
The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);
Inventors:
David M. Kurtz, San Carlos, CA (US);
Maximilian Diehn, San Carlos, CA (US);
Arash Ash Alizadeh, San Mateo, CA (US);
Assignee:
The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 30/10 (2019.01); C12N 15/10 (2006.01); C12Q 1/6869 (2018.01); C12Q 1/6874 (2018.01); C12Q 1/6886 (2018.01); G16B 20/00 (2019.01); G16B 20/10 (2019.01); G16B 20/20 (2019.01); G16B 30/00 (2019.01); G16B 35/20 (2019.01); G16B 40/00 (2019.01); G16H 10/40 (2018.01); G16H 20/10 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); G16H 70/60 (2018.01); G16H 10/60 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12N 15/1089 (2013.01); C12Q 1/6869 (2013.01); C12Q 1/6874 (2013.01); G16B 20/00 (2019.02); G16B 20/10 (2019.02); G16B 20/20 (2019.02); G16B 30/00 (2019.02); G16B 30/10 (2019.02); G16B 35/20 (2019.02); G16B 40/00 (2019.02); G16H 10/40 (2018.01); G16H 20/10 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); G16H 70/60 (2018.01); C12Q 2600/112 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/7028 (2013.01); G16H 10/60 (2018.01);
Abstract
Processes and materials to detect cancer from a biopsy are described. In some cases, cell-free nucleic acids can be sequenced, and the sequencing result can be utilized to detect sequences derived from a neoplasm. Detection of somatic variants occurring in phase can indicate the presence of cancer in a diagnostic scan and a clinical intervention can be performed.